NCT03139838

Brief Summary

This is a pragmatic, stepped-wedge, cluster randomized trial testing the real-world effectiveness of two different electronic health record (EHR) behavioral interventions in improving a number of patient- and family-centered processes and outcomes of care among seriously ill hospitalized patients. The investigators hypothesize that outcomes can be improved without raising costs by requiring intensive care unit clinicians to (i) document a prognostic estimate and (ii) provide a justification if they choose not to offer patients the option of comfort-oriented care. To test this hypothesis the investigators will conduct a 33-month trial at 17 intensive care units in 10 hospitals using the same Cerner EHR within Atrium Health System.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 4, 2017

Completed
9 months until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2021

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

August 8, 2022

Status Verified

August 1, 2022

Enrollment Period

3.2 years

First QC Date

April 25, 2017

Last Update Submit

August 3, 2022

Conditions

Keywords

Palliative CarePragmatic Clinical TrialElectronic Health RecordsEconomics, Behavioral

Outcome Measures

Primary Outcomes (1)

  • Composite Measure: Length of Stay and In-Hospital Mortality

    The primary outcome is a composite measure of hospital length-of-stay and mortality that ranks deaths along the length-of-stay distribution

    Duration of hospital stay, an expected average of 16 days

Secondary Outcomes (20)

  • Change in code status

    Duration of hospital stay, an expected average of 16 days

  • Initiation of additional forms of life-support

    Duration of hospital stay, an expected average of 16 days

  • Palliative care consult

    Duration of hospital stay, an expected average of 16 days

  • Time to palliative care consult

    Duration of hospital stay, an expected average of 16 days

  • Palliative withdrawal of mechanical ventilation

    Duration of hospital stay, an expected average of 16 days

  • +15 more secondary outcomes

Study Arms (4)

EHR-Based Intervention A

ACTIVE COMPARATOR

Intervention A (Prognostication) will be an EHR-based screen prompt triggered for eligible patients. The intervention will consist of no more than two questions that can be completed in two minutes or less. Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.

Behavioral: EHR-Based Intervention A

EHR-Based Intervention B

ACTIVE COMPARATOR

Intervention B (Accountable Justification) will be an EHR-based screen prompt triggered for eligible patients. The intervention will consist of no more than two questions that can be completed in two minutes or less. Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.

Behavioral: EHR-Based Intervention B

Combined EHR-Based Intervention (A+B)

ACTIVE COMPARATOR

Intervention A and B prompts will be combined and triggered for eligible patients simultaneously. Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.

Behavioral: EHR-Based Intervention ABehavioral: EHR-Based Intervention B

Pre-Intervention (Control)

NO INTERVENTION

There is no trial-driven approach to care. All hospitals contribute a minimum of 5 months of outcomes data prior to adopting the intervention. Pre-specified outcomes data will be electronically extracted for patients meeting eligibility criteria but there will be no attempt to influence delivery of usual care within the hospital. The length of the control phase will differ at each hospital, dependent on the sequence in which hospitals are assigned to switch to the intervention phase.

Interventions

Intervention A will be a prompt for clinicians to document an estimated prognosis for patients at 6 months, and an assessment of predicted functional outcome if expected to survive.

Also known as: Prognostication
Combined EHR-Based Intervention (A+B)EHR-Based Intervention A

Intervention B will entail a prompt for clinicians to provide a reason for not offering patients and their families the alternative of care focused entirely on comfort despite recommendations from critical care professional societies to do so for patients at high risk for death or severely impaired functional recovery.

Also known as: Accountable Justification
Combined EHR-Based Intervention (A+B)EHR-Based Intervention B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years old; AND
  • Admitted to 1 of the 17 participating ICUs; AND
  • Receipt of continuous mechanical ventilation for ≥ 48 hours (without interruption); AND
  • ≥ 1 life-limiting illness present on admission (ICD-9/10 code or discrete medical history data from EHR in prior 12 months):
  • Chronic obstructive pulmonary disease
  • Cirrhosis
  • Congestive heart failure
  • Dementia (all types)
  • End-stage renal disease
  • Hematologic malignancy
  • Metastatic malignancy
  • Motor neuron disease
  • Pulmonary fibrosis
  • Solid organ malignancy

You may not qualify if:

  • \) Patients younger than 18 years old are excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Carolinas HealthCare System Stanly

Albemarle, North Carolina, 28001, United States

Location

Carolinas HealthCare System, NorthEast

Charlotte, North Carolina, 28025, United States

Location

Carolinas Medical Center

Charlotte, North Carolina, 28203, United States

Location

Atrium Health CMC-Mercy

Charlotte, North Carolina, 28207, United States

Location

Atrium Health Pineville

Charlotte, North Carolina, 28210, United States

Location

Atrium Health University City

Charlotte, North Carolina, 28262, United States

Location

Atrium Health Lincoln

Lincolnton, North Carolina, 28092, United States

Location

Atrium Health Union

Monroe, North Carolina, 28112, United States

Location

Carolinas HealthCare System Blue Ridge-Morganton

Morganton, North Carolina, 28655, United States

Location

Atrium Health Cleveland

Shelby, North Carolina, 28150, United States

Location

Related Publications (2)

  • Courtright KR, Singh J, Dress EM, Bayes B, Harhay MO, Chowdhury M, Lu Y, Lee KM, Small DS, Whitman C, Tian J, Madden V, Hetherington T, Placket L, Sullivan DM, Burke HL, Green MB, Halpern SD. Nudging Clinicians to Promote Serious Illness Communication for Critically Ill Patients: A Pragmatic Cluster Randomized Trial. JAMA Intern Med. 2025 May 1;185(5):510-520. doi: 10.1001/jamainternmed.2025.0090.

  • Courtright KR, Dress EM, Singh J, Bayes BA, Chowdhury M, Small DS, Hetherington T, Plickert L, Detsky ME, Doctor JN, Harhay MO, Burke HL, Green MB, Huynh T, Sullivan DM, Halpern SD; PONDER-ICU Investigative Team. Prognosticating Outcomes and Nudging Decisions with Electronic Records in the Intensive Care Unit Trial Protocol. Ann Am Thorac Soc. 2021 Feb;18(2):336-346. doi: 10.1513/AnnalsATS.202002-088SD.

MeSH Terms

Conditions

Critical IllnessBehavior

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Scott D Halpern, PhD, MD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2017

First Posted

May 4, 2017

Study Start

February 1, 2018

Primary Completion

April 24, 2021

Study Completion

June 30, 2022

Last Updated

August 8, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations